Annual SG&A
$1.19 B
+$177.70 M+17.63%
31 December 2023
Summary:
DexCom annual selling, general & administrative expenses is currently $1.19 billion, with the most recent change of +$177.70 million (+17.63%) on 31 December 2023. During the last 3 years, it has risen by +$374.90 million (+46.26%). DXCM annual SG&A is now at all-time high.DXCM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$306.40 M
-$26.30 M-7.91%
30 September 2024
Summary:
DexCom quarterly selling, general & administrative expenses is currently $306.40 million, with the most recent change of -$26.30 million (-7.91%) on 30 September 2024. Over the past year, it has increased by +$2.80 million (+0.92%). DXCM quarterly SG&A is now -7.91% below its all-time high of $332.70 million, reached on 30 June 2024.DXCM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$4.95 B
+$680.80 M+15.96%
30 September 2024
Summary:
DexCom TTM selling, general & administrative expenses is currently $4.95 billion, with the most recent change of +$680.80 million (+15.96%) on 30 September 2024. Over the past year, it has increased by +$3.76 billion (+317.28%). DXCM TTM SG&A is now at all-time high.DXCM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +0.9% | +317.3% |
| 3 y3 years | +46.3% | +29.1% | +509.9% |
| 5 y5 years | +129.9% | +137.5% | +859.2% |
DXCM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +46.3% | -7.9% | +40.0% | at high | +3397.6% |
| 5 y | 5 years | at high | +129.9% | -7.9% | +137.5% | at high | +257.4% |
| alltime | all time | at high | >+9999.0% | -7.9% | >+9999.0% | at high | +252.4% |
DexCom Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $306.40 M(-7.9%) | $1.26 B(+1.6%) |
| June 2024 | - | $332.70 M(+4.2%) | $1.24 B(+2.8%) |
| Mar 2024 | - | $319.30 M(+5.2%) | $1.21 B(+1.9%) |
| Dec 2023 | $1.19 B(+17.6%) | $303.60 M(+6.0%) | $1.19 B(-0.1%) |
| Sept 2023 | - | $286.40 M(-4.2%) | $1.19 B(+4.6%) |
| June 2023 | - | $299.00 M(+0.9%) | $1.14 B(+4.6%) |
| Mar 2023 | - | $296.40 M(-2.9%) | $1.09 B(+7.7%) |
| Dec 2022 | $1.01 B(+24.3%) | $305.30 M(+30.1%) | $1.01 B(+7.2%) |
| Sept 2022 | - | $234.60 M(-5.7%) | $939.80 M(+4.0%) |
| June 2022 | - | $248.90 M(+13.7%) | $903.70 M(+7.4%) |
| Mar 2022 | - | $218.90 M(-7.8%) | $841.30 M(+3.7%) |
| Dec 2021 | $810.50 M(+30.6%) | $237.40 M(+19.6%) | $811.00 M(+8.2%) |
| Sept 2021 | - | $198.50 M(+6.4%) | $749.50 M(+5.6%) |
| June 2021 | - | $186.50 M(-1.1%) | $709.60 M(+7.6%) |
| Mar 2021 | - | $188.60 M(+7.2%) | $659.50 M(+6.3%) |
| Dec 2020 | $620.70 M(+20.4%) | $175.90 M(+10.9%) | $620.70 M(+8.2%) |
| Sept 2020 | - | $158.60 M(+16.3%) | $573.80 M(+6.4%) |
| June 2020 | - | $136.40 M(-8.9%) | $539.40 M(-0.4%) |
| Mar 2020 | - | $149.80 M(+16.1%) | $541.30 M(+5.0%) |
| Dec 2019 | $515.70 M(+19.2%) | $129.00 M(+3.9%) | $515.70 M(+3.4%) |
| Sept 2019 | - | $124.20 M(-10.2%) | $498.80 M(+4.1%) |
| June 2019 | - | $138.30 M(+11.4%) | $479.20 M(+6.0%) |
| Mar 2019 | - | $124.20 M(+10.8%) | $452.20 M(+4.5%) |
| Dec 2018 | $432.80 M(+23.9%) | $112.10 M(+7.2%) | $432.80 M(+4.7%) |
| Sept 2018 | - | $104.60 M(-6.0%) | $413.50 M(+5.2%) |
| June 2018 | - | $111.30 M(+6.2%) | $393.10 M(+6.9%) |
| Mar 2018 | - | $104.80 M(+12.9%) | $367.60 M(+5.3%) |
| Dec 2017 | $349.20 M(+22.0%) | $92.80 M(+10.2%) | $349.20 M(+4.1%) |
| Sept 2017 | - | $84.20 M(-1.9%) | $335.50 M(+2.6%) |
| June 2017 | - | $85.80 M(-0.7%) | $327.00 M(+5.3%) |
| Mar 2017 | - | $86.40 M(+9.2%) | $310.50 M(+8.5%) |
| Dec 2016 | $286.20 M(+44.5%) | $79.10 M(+4.5%) | $286.20 M(+6.7%) |
| Sept 2016 | - | $75.70 M(+9.2%) | $268.20 M(+9.6%) |
| June 2016 | - | $69.30 M(+11.6%) | $244.80 M(+10.9%) |
| Mar 2016 | - | $62.10 M(+1.6%) | $220.70 M(+11.5%) |
| Dec 2015 | $198.00 M(+54.2%) | $61.10 M(+16.8%) | $198.00 M(+14.4%) |
| Sept 2015 | - | $52.30 M(+15.7%) | $173.10 M(+12.0%) |
| June 2015 | - | $45.20 M(+14.7%) | $154.50 M(+10.2%) |
| Mar 2015 | - | $39.40 M(+8.8%) | $140.20 M(+9.2%) |
| Dec 2014 | $128.40 M | $36.20 M(+7.4%) | $128.40 M(+10.7%) |
| Sept 2014 | - | $33.70 M(+9.1%) | $116.00 M(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | $30.90 M(+12.0%) | $103.90 M(+10.9%) |
| Mar 2014 | - | $27.60 M(+16.0%) | $93.70 M(+11.3%) |
| Dec 2013 | $84.20 M(+31.6%) | $23.80 M(+10.2%) | $84.20 M(+8.4%) |
| Sept 2013 | - | $21.60 M(+4.3%) | $77.70 M(+8.7%) |
| June 2013 | - | $20.70 M(+14.4%) | $71.50 M(+7.2%) |
| Mar 2013 | - | $18.10 M(+4.6%) | $66.70 M(+4.2%) |
| Dec 2012 | $64.00 M(+25.2%) | $17.30 M(+12.3%) | $64.00 M(+3.9%) |
| Sept 2012 | - | $15.40 M(-3.1%) | $61.60 M(+3.6%) |
| June 2012 | - | $15.90 M(+3.2%) | $59.44 M(+6.6%) |
| Mar 2012 | - | $15.40 M(+3.4%) | $55.78 M(+9.2%) |
| Dec 2011 | $51.10 M(+26.2%) | $14.90 M(+12.5%) | $51.10 M(+10.7%) |
| Sept 2011 | - | $13.24 M(+8.1%) | $46.17 M(+6.6%) |
| June 2011 | - | $12.24 M(+14.2%) | $43.31 M(+4.5%) |
| Mar 2011 | - | $10.72 M(+7.5%) | $41.42 M(+2.3%) |
| Dec 2010 | $40.50 M(+15.1%) | $9.97 M(-4.0%) | $40.50 M(+1.4%) |
| Sept 2010 | - | $10.38 M(+0.1%) | $39.93 M(+3.7%) |
| June 2010 | - | $10.36 M(+5.8%) | $38.50 M(+3.8%) |
| Mar 2010 | - | $9.79 M(+4.2%) | $37.09 M(+5.4%) |
| Dec 2009 | $35.20 M(+27.2%) | $9.40 M(+5.0%) | $35.20 M(+6.2%) |
| Sept 2009 | - | $8.95 M(-0.0%) | $33.15 M(+7.4%) |
| June 2009 | - | $8.95 M(+13.3%) | $30.86 M(+5.8%) |
| Mar 2009 | - | $7.90 M(+7.5%) | $29.15 M(+5.4%) |
| Dec 2008 | $27.67 M(+23.3%) | $7.35 M(+10.5%) | $27.67 M(+6.5%) |
| Sept 2008 | - | $6.65 M(-8.2%) | $25.97 M(+2.8%) |
| June 2008 | - | $7.25 M(+12.9%) | $25.26 M(+7.6%) |
| Mar 2008 | - | $6.42 M(+13.6%) | $23.49 M(+4.7%) |
| Dec 2007 | $22.44 M(+6.3%) | $5.65 M(-4.9%) | $22.44 M(+1.8%) |
| Sept 2007 | - | $5.94 M(+8.7%) | $22.05 M(-4.9%) |
| June 2007 | - | $5.47 M(+1.8%) | $23.18 M(+2.4%) |
| Mar 2007 | - | $5.37 M(+2.0%) | $22.64 M(+7.2%) |
| Dec 2006 | $21.11 M(+273.0%) | $5.26 M(-25.6%) | $21.11 M(+20.6%) |
| Sept 2006 | - | $7.07 M(+43.4%) | $17.51 M(+42.9%) |
| June 2006 | - | $4.93 M(+28.4%) | $12.25 M(+39.0%) |
| Mar 2006 | - | $3.84 M(+131.6%) | $8.81 M(+55.7%) |
| Dec 2005 | $5.66 M(+254.3%) | $1.66 M(-8.8%) | $5.66 M(+41.5%) |
| Sept 2005 | - | $1.82 M(+21.5%) | $4.00 M(+83.3%) |
| June 2005 | - | $1.50 M(+118.0%) | $2.18 M(+218.0%) |
| Mar 2005 | - | $686.60 K | $686.60 K |
| Dec 2004 | $1.60 M(+27.8%) | - | - |
| Dec 2003 | $1.25 M(-25.8%) | - | - |
| Dec 2001 | $1.69 M(+51.5%) | - | - |
| Dec 2000 | $1.11 M | - | - |
FAQ
- What is DexCom annual selling, general & administrative expenses?
- What is the all time high annual SG&A for DexCom?
- What is DexCom quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for DexCom?
- What is DexCom quarterly SG&A year-on-year change?
- What is DexCom TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for DexCom?
- What is DexCom TTM SG&A year-on-year change?
What is DexCom annual selling, general & administrative expenses?
The current annual SG&A of DXCM is $1.19 B
What is the all time high annual SG&A for DexCom?
DexCom all-time high annual selling, general & administrative expenses is $1.19 B
What is DexCom quarterly selling, general & administrative expenses?
The current quarterly SG&A of DXCM is $306.40 M
What is the all time high quarterly SG&A for DexCom?
DexCom all-time high quarterly selling, general & administrative expenses is $332.70 M
What is DexCom quarterly SG&A year-on-year change?
Over the past year, DXCM quarterly selling, general & administrative expenses has changed by +$2.80 M (+0.92%)
What is DexCom TTM selling, general & administrative expenses?
The current TTM SG&A of DXCM is $4.95 B
What is the all time high TTM SG&A for DexCom?
DexCom all-time high TTM selling, general & administrative expenses is $1.26 B
What is DexCom TTM SG&A year-on-year change?
Over the past year, DXCM TTM selling, general & administrative expenses has changed by +$3.76 B (+317.28%)